RT Journal Article SR Electronic T1 Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.18.20196451 DO 10.1101/2020.09.18.20196451 A1 Kylie P Glanville A1 Jonathan R I Coleman A1 David M Howard A1 Oliver Pain A1 Ken B Hanscombe A1 Bradley Jermy A1 Ryan Arathimos A1 Christopher Hübel A1 Gerome Breen A1 Paul F O’Reilly A1 Cathryn M Lewis YR 2020 UL http://medrxiv.org/content/early/2020/12/13/2020.09.18.20196451.abstract AB Background The UK Biobank (UKB) contains data with varying degrees of reliability and completeness for assessing depression. A third of participants completed a Mental Health Questionnaire (MHQ) containing the gold-standard Composite International Diagnostic Interview (CIDI) criteria for assessing mental health disorders.Aims To investigate whether multiple observations of depression from sources other than the MHQ can enhance the validity of Major Depressive Disorder.Methods In participants who did not complete the MHQ (n = 325k), we calculated the number of other depression measures endorsed, e.g. from hospital episode statistics and interview data. We compared cases defined this way to CIDI-defined cases for several estimates: the variance explained by polygenic risk scores (PRS), area under the curve attributable to PRS, SNP-based heritability, and genetic correlations with summary statistics from the Psychiatric Genomics Consortium Major Depressive Disorder (PGC MDD) GWAS.Results The strength of the genetic contribution increased with the number of measures endorsed. For example, SNP-based heritability increased from 7% in cases who endorsed only one measure of depression, to 21% in cases who endorsed four or five measures of depression. The strength of the genetic contribution to cases defined by at least two measures approximated that for CIDI-defined cases. Most genetic correlations between UKB and PGC MDD exceeded 0.7, but there was variability between pairwise comparisons.Conclusions Multiple measures of depression can serve as a reliable approximation for case-status where the CIDI measure is not available, indicating sample size can be optimised using the entire suite of UKB data.Competing Interest StatementCML is a member of the SAB for Myriad Neuroscience. The remaining authors declare no competing interests.Funding StatementThis work was supported by the UK Medical Research Council (PhD studentship to KPG; grant MR/N015746/1). This paper represents independent research part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. DMH is supported by a Sir Henry Wellcome Postdoctoral Fellowship (Reference 213674/Z/18/Z) and a 2018 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (Ref: 27404).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank received ethical approval from the North West - Haydock Research Ethics Committee (reference 16/NW/0274). This study was conducted under UK Biobank application number 18177.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable from UK Biobank subject to standard procedures (www.ukbiobank.ac.uk). The full GWAS summary statistics for the 23andMe discovery data set will be made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit https://research.23andme.com/collaborate/#publication for more information and to apply to access the data. https://www.ukbiobank.ac.uk/ https://research.23andme.com/collaborate/#publication